Reports From the Field

COVID-19 Screening and Testing Among Patients With Neurologic Dysfunction: The Neuro-COVID-19 Time-out Process and Checklist


 

References

During the pilot period of the NCOT-PC, 14 new patients were admitted to the NSICU service. Nine (64%) of these had neurologic dysfunction, and the NCOT-PC was used to determine whether Med-Com should be called based on the patients’ likelihood (high vs low) of needing a COVID-19 test. Of those patients with neurologic dysfunction, 7 (78%) were deemed to have a high likelihood of needing a COVID-19 test based on the NCOT-PC. Med-Com was contacted regarding these patients, and all were deemed to require the COVID-19 test by Med-Com and were transitioned into PUI status per institutional policy (Table).

Patient Characteristics Identified by NCOT-PC Screening Tool

Discussion

The NCOT-PC project improved and standardized the process of identifying and screening patients with neurologic dysfunction for COVID-19 testing. The screening tool is feasible to use, and it decreased inadvertent unprotected exposure of patients and health care workers.

The NCOT-PC was easy to administer. Educating the staff regarding the new process took only a few minutes and involved a meeting with the nurse manager, NPs, fellows, residents, and attendings. We found that this process works well in tandem with the standard institutional processes in place in terms of Protected Code Stroke pathway, PUI isolation, PPE use, and Med-Com screening for COVID-19 testing. Med-Com was called only if the patient fulfilled the checklist criteria. In addition, no extra cost was attributed to implementing the NCOT-PC, since we utilized imaging that was already done as part of the standard of care for patients with neurologic dysfunction.

The standardization of the process of screening for COVID-19 testing among patients with neurologic dysfunction improved patient selection. Before the NCOT-PC, there was no consistency in terms of who should get tested and the reason for testing patients with neurologic dysfunction. Patients can pass through the ED and arrive in the NSICU with an unclear screening status, which may cause inadvertent patient and health care worker exposure to COVID-19. With the NCOT-PC, we have avoided instances of inadvertent staff or patient exposure in the NSICU.

The NCOT-PC was adopted into the NSICU process after the first week it was piloted. Beyond the NSICU, the application of the NCOT-PC can be extended to any patient presentation that precludes standard screening, such as ED and interhospital transfers for stroke codes, trauma codes, code blue, or myocardial infarction codes. In our department, as we started the process of PCS for stroke codes, we included NCOT-PC for stroke patients with neurologic dysfunction.

Pages

Recommended Reading

COVID-19 and the psychological side effects of PPE
Journal of Clinical Outcomes Management
Dr. Fauci: ‘About 40%-45% of infections are asymptomatic’
Journal of Clinical Outcomes Management
2020-2021 respiratory viral season: Onset, presentations, and testing likely to differ in pandemic
Journal of Clinical Outcomes Management
Many Americans still concerned about access to health care
Journal of Clinical Outcomes Management
Low vitamin D in COVID-19 predicts ICU admission, poor survival
Journal of Clinical Outcomes Management
Survey quantifies COVID-19’s impact on oncology
Journal of Clinical Outcomes Management
Observational study again suggests lasting impact of COVID-19 on heart
Journal of Clinical Outcomes Management
CDC adds then retracts aerosols as main COVID-19 mode of transmission
Journal of Clinical Outcomes Management
Systemic Corticosteroids in Critically Ill Patients With COVID-19
Journal of Clinical Outcomes Management
“I Really Didn’t Want To Come In”: The Unseen Effects of COVID-19 on Children
Journal of Clinical Outcomes Management